Duration of Immune Response to Influenza Vaccination in Patients With RA

Completed · Phase 4

Conditions studied: Rheumatoid Arthritis

In brief

The main objective is to evaluate the strength and duration of immune response after influenza vaccination in patients with Rheumatoid Arthritis (RA) receiving treatment with biological agents as compared to a group healthy controls who do not have RA. Influenza vaccine titers will be drawn 3 times: at Baseline(prior to vaccination), 4-6 weeks post vaccination, and 5-6 months post vaccination. Influenza vaccination will be done at the baseline visit after the baseline blood draw.

Key facts

Study ID
NCT02311855
Run by
Bassett Healthcare
People needed
87
Starts
2014-08-01
Expected to finish
2016-02-01
Last updated by the study team
2017-01-06

Who can join

Age: 40 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.